21.06.2011 • Videos

In Conversation with Dr. Heinz Sieger, CEO of CU Chemie Uetikon

CU Chemie Uetikon CEO Heinz Sieger spoke to CHEManager Europe Editor Brandi Schuster about what his customers are looking for when it comes to custom synthesis. Sieger is also active in industry groups such as the CASID, a society for custom synthesis in Germany, and the European Fine Chemicals Group (EFCG), which works to create a level playing field for European manufacturers of APIs and excipients.

To learn more about CASID, click here.

To learn more about the EFCG, click here.

Company

CU Chemie Uetikon

Raiffeisenstr. 4
77933 Lahr
Germany

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read